Received Apr 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 947357 | IM / LA |
Presents with macular redness at the injection site in the left deltoid, radiating toward the upper chest; reports pruritus in this area as of 13:00 on April 16, 2026. Was referred for medical attention.